UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals

PLoS genetics, 2019-06, Vol.15 (6), p.e1008181

2019

Volltextzugriff (PDF)

Direct-acting antiviral treatment for hepatitis C

The Lancet (British edition), 2019-04, Vol.393 (10179), p.1392-1394

2019

Volltextzugriff (PDF)

Editorial: hepatocellular carcinoma risk prediction models following DAA‐mediated SVR—more evidence needed

Alimentary pharmacology & therapeutics, 2022-01, Vol.55 (1), p.135-136

2022

Volltextzugriff (PDF)

Hematemesis, Abnormal Liver Function, and Polymicrobial Bacteremia: A Rare Complication of a Common Cancer

Gastroenterology (New York, N.Y. 1943), 2021-03, Vol.160 (4), p.1031-1033

2021

Volltextzugriff (PDF)

Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis

Hepatology (Baltimore, Md.), 2018-09, Vol.68 (3), p.1125-1139

2018

Volltextzugriff (PDF)

Editorial on "Maximize Donor Cornea Use in a Hepatitis B Endemic Area via Serology Matching"

Transplantation, 2023-06, Vol.107 (6), p.1242-1243

2023

Volltextzugriff (PDF)

Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals

Expert opinion on drug safety, 2017-06, Vol.16 (6), p.651-672

2017

Volltextzugriff (PDF)

Non-invasive fibrosis algorithms are clinically useful for excluding cirrhosis in prisoners living with hepatitis C

PloS one, 2020-11, Vol.15 (11), p.e0242101-e0242101

2020

Volltextzugriff (PDF)

The Importance of Prisons in Achieving Hepatitis C Elimination: Insights from the Australian Experience

Viruses, 2022-02, Vol.14 (3), p.497

2022

Volltextzugriff (PDF)

Hepatitis B and Hepatitis C Virus Infection Promote Liver Fibrogenesis through a TGF-β1-Induced OCT4/Nanog Pathway

The Journal of immunology (1950), 2022-02, Vol.208 (3), p.672-684

2022

Volltextzugriff (PDF)

Hepatitis C Virus Infection in Pregnancy: An Update

Gastroenterology nursing, 2020-01, Vol.43 (1), p.12-21

2020

Volltextzugriff (PDF)

Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection

Journal of hepatology, 2020-07, Vol.73 (1), p.62-71

2020

Volltextzugriff (PDF)

A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha–Inducible Protein 6

Hepatology (Baltimore, Md.), 2019-03, Vol.69 (3), p.1004-1019

2019

Volltextzugriff (PDF)

New approaches in viraemic organ transplantation and antiviral therapies

Nature reviews. Gastroenterology & hepatology, 2020-02, Vol.17 (2), p.78-79

2020

Volltextzugriff (PDF)

Helicobacter pylori antimicrobial resistance in Melbourne, Australia. Time to review therapeutic guidelines?

Internal medicine journal, 2021-11, Vol.51 (11), p.1919-1926

2021

Volltextzugriff (PDF)

Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types

Hepatology (Baltimore, Md.), 2016-12, Vol.64 (6), p.1951-1968

2016

Volltextzugriff (PDF)

Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection

The Journal of infectious diseases, 2018-09, Vol.218 (9), p.1394-1403

2018

Volltextzugriff (PDF)

CRISPR-Cas13b-mediated suppression of HBV replication and protein expression

Journal of hepatology, 2024-05

2024

Volltextzugriff (PDF)

COVID-19 induced liver function abnormality associates with age

Aging (Albany, NY.), 2020-07, Vol.12 (14), p.13895-13904

2020

Volltextzugriff (PDF)

Dynamic changes in innate immune responses during direct‐acting antiviral therapy for HCV infection

Journal of viral hepatitis, 2019-03, Vol.26 (3), p.362-372

2019

Volltextzugriff (PDF)

MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway

Journal of virology, 2018-04, Vol.92 (7)

2018

Volltextzugriff (PDF)

The risk of hepatitis C virus recurrence in hepatitis C virus‐infected patients treated with direct‐acting antivirals after achieving a sustained virological response: A comprehensive analysis

Liver international, 2021-10, Vol.41 (10), p.2341-2357

2021

Volltextzugriff (PDF)

Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase

Cellular and molecular gastroenterology and hepatology, 2021-01, Vol.12 (4), p.1297-1310

2021

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(99)

Publikationsform

Artikel
(115)
Berichte
(1)

Sprache

Englisch
(116)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals

Direct-acting antiviral treatment for hepatitis C

Editorial: hepatocellular carcinoma risk prediction models following DAA‐mediated SVR—more evidence needed

Hematemesis, Abnormal Liver Function, and Polymicrobial Bacteremia: A Rare Complication of a Common Cancer

Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis

Editorial on "Maximize Donor Cornea Use in a Hepatitis B Endemic Area via Serology Matching"

Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals

Non-invasive fibrosis algorithms are clinically useful for excluding cirrhosis in prisoners living with hepatitis C

The Importance of Prisons in Achieving Hepatitis C Elimination: Insights from the Australian Experience

Hepatitis B and Hepatitis C Virus Infection Promote Liver Fibrogenesis through a TGF-β1-Induced OCT4/Nanog Pathway

Hepatitis C Virus Infection in Pregnancy: An Update

Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection

A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha–Inducible Protein 6

New approaches in viraemic organ transplantation and antiviral therapies

Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis

Helicobacter pylori antimicrobial resistance in Melbourne, Australia. Time to review therapeutic guidelines?

Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types

Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection

CRISPR-Cas13b-mediated suppression of HBV replication and protein expression

COVID-19 induced liver function abnormality associates with age

Dynamic changes in innate immune responses during direct‐acting antiviral therapy for HCV infection

MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway

The risk of hepatitis C virus recurrence in hepatitis C virus‐infected patients treated with direct‐acting antivirals after achieving a sustained virological response: A comprehensive analysis

An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection

Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase

Suchergebnisse filtern